A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/40 (2006.01) A61K 31/445 (2006.01)
Patent
CA 2483929
A method for inhibiting platelet aggregation in a patient in need thereof, comprising 1) administering to the patient a bolus injection of an active drug, in an amount of between about 25 ~g/kg, and 2) administering to the patient, after the bolus injection, an intravenous infusion for a period of between about 12 hours and about 72 hours, of the active drug, in an amount of about 0.15 ~g/kg/min, wherein the active drug is tirofiban or a salt thereof.
L'invention concerne une méthode qui permet d'inhiber l'agrégation plaquettaire chez un patient nécessitant un tel traitement. Cette méthode consiste : 1) à administrer au patient une injection bolus d'un médicament actif à raison d'environ 25 ?g/kg ; et 2) à administrer au patient, après l'injection bolus, une infusion intraveineuse du médicament actif pendant une période allant d'environ 12 heures à environ 72 heures, à raison d'environ 0,15 ?g/kg/min. Le médicament actif est du tirofiban ou un sel de ce dernier.
Dibattiste Peter M.
Schneider David
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
A method for inhibiting platelet aggregation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A method for inhibiting platelet aggregation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method for inhibiting platelet aggregation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1385852